Heparin contraindications: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{CMG}} | |||
Heparin sodium should not be used in patients: | Heparin sodium should not be used in patients: | ||
| Line 7: | Line 8: | ||
* With an uncontrollable active bleeding state, except when this is due to disseminated intravascular coagulation. | * With an uncontrollable active bleeding state, except when this is due to disseminated intravascular coagulation. | ||
{{FDA}} | |||
Revision as of 21:19, 15 February 2009
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Heparin sodium should not be used in patients:
- With severe thrombocytopenia;
- In whom suitable blood-coagulation tests (the whole-blood clotting time, partial thromboplastin time, etc.) cannot be performed at appropriate intervals (this contraindication refers to full-dose Heparin; there is usually no need to monitor coagulation parameters in patients receiving low-dose Heparin);
- With an uncontrollable active bleeding state, except when this is due to disseminated intravascular coagulation.
Adapted from the FDA Package Insert.